Request Demo
Last update 28 Feb 2026
Molgramostim biosimilar(Chinese Academy of Sciences)
Last update 28 Feb 2026
Overview
Basic Info
Drug Type Biosimilar, Colony-stimulating factors |
Synonyms 重组人粒细胞-巨噬细胞集落刺激因子 |
Target |
Action stimulants |
Mechanism CSF-2R stimulants(Granulocyte-macrophage colony-stimulating factor receptor stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 1191632844
The sequence is quoted from: *****
Related
1
Clinical Trials associated with Molgramostim biosimilar(Chinese Academy of Sciences)CTR20150133
评价重组人粒细胞-巨噬细胞集落刺激因子胶囊有效性和安全性的多中心、随机、平行组双盲对照的Ⅱ期临床试验
[Translation] A multicenter, randomized, parallel-group, double-blind controlled phase II clinical trial to evaluate the efficacy and safety of recombinant human granulocyte-macrophage colony-stimulating factor capsules
100 Clinical Results associated with Molgramostim biosimilar(Chinese Academy of Sciences)
Login to view more data
100 Translational Medicine associated with Molgramostim biosimilar(Chinese Academy of Sciences)
Login to view more data
100 Patents (Medical) associated with Molgramostim biosimilar(Chinese Academy of Sciences)
Login to view more data
100 Deals associated with Molgramostim biosimilar(Chinese Academy of Sciences)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Leukopenia | Phase 2 | China | 13 Mar 2015 | |
| Neoplasms | Phase 2 | China | 13 Mar 2015 | |
| Neutropenia | Phase 2 | China | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free